In the fast-evolving world of neurology, Cerebral Amyloid Angiopathy (CAA) — once a shadowy player in the landscape of neurodegenerative diseases — is now commanding the spotlight. With the rising prevalence of age-related brain disorders, the Cerebral Amyloid Angiopathy Treatment Market is undergoing a seismic shift, driven by a potent combination of innovation,...